Vincenzo Cerullo
@vincersurf
Great news, congrats! Vincenzo Cerullo Manlio Fusciello Erkko Ylösmäki and Giuseppe Balistreri #ftdk University of Helsinki #ViikkiCampus
New platforms are needed for pre-treatment testing of cancer therapies to avoid treating patients who are unlikely to respond. Grönholm et al discuss patient-derived tumor organoid cultures testing as testing platforms for #Immunotherapy Vincenzo Cerullo bit.ly/3grI93C
An old idea that's finally coming to fruition: Infect cancer patients with viruses to save their lives. For Discover Magazine featuring Vincenzo Cerullo and many others! discovermagazine.com/health/how-vir…
Patient-Derived Organoids for Precision Cancer Immunotherapy cancerres.aacrjournals.org/content/81/12/… A new paper by #MikaelaGrönholm #MichaelaFeodoroff & al. from the Vincenzo Cerullo lab #DrugResearchProgram #ftdk #viikkicampus Life Sciences University of Helsinki
Valo Tx has submitted a clinical trial application to the German Regulatory Agency (PEI) for a Phase 1 trial of our lead immuno-oncology product, PeptiCRAd-1! valotx.com/article/valo-t… #clinicalresearch #immunotherapy #clinicaltrial #collaboration Helsinki Innovation Services Ltd Vincenzo Cerullo
New #JITC article: Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin Vincenzo Cerullo ow.ly/8Xq850FBBHM
New #JITC article: Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids Vincenzo Cerullo ow.ly/Z8ka50FQcXG
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy 🧪 mdpi.com/1180484 A new paper by Karita Sara Erkko Ylösmäki Vincenzo Cerullo & al. #DrugResearchProgram #FTDK #viikkicampus Life Sciences University of Helsinki
Dendriittisoluihin perustuvia syövän immuunihoitoja on mahdollista tehostaa selviää University of Helsinki tutkimuksessa, jossa mukana Susanna Fagerholm Vincenzo Cerullo & co. #bytdk #ftdk #syöpä #immuunihoito #terveys helsinki.fi/fi/uutiset/ter…
Only one Centre of Excellence for the whole field of medicine/biomedicine in the *whole*country! Only one AcaProf for the fields in the past call. Funding of outstanding research is based on complete lottery. Suomen Akatemia | Research Council of Finland 1/2
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations jitc.bmj.com/content/9/8/e0… A new paper by Erkko Ylösmäki Sara Manlio Fusciello @miqumik Vincenzo Cerullo & al. #ftdk #viikkicampus Life Sciences University of Helsinki
Remember to take our survey 📣 We’re trying to pinpoint the best funding scheme or model for supporting the research and careers of #EarlyCareerResearchers. Learn more here 👉 aka.fi/en/about-us/wh… The survey is open until 23 Oct ❗ link.webropolsurveys.com/S/251CAC249244… #ResearchFunding
This is a fantastic news! a dream become true! I could not be more excited to see how it continues! The conception of the PeptiCRAD technology has been supported by European Research Council (ERC) Consolidator grant in 2015 and it is now great to see how VALOtx is taking it to clinic!
This is a fantastic news! a dream become true! I could not be more excited to see how it continues! The conception of the PeptiCRAD technology has been supported by European Research Council (ERC) Consolidator grant in 2015 and it is now great to see how VALOtx is taking it to clinic!
We are thrilled to work on this project! We have been developing in the Lab for long time and now I am happy to see that there is a fantastic team of very motivated scientists to really turn this into a product! Instrumental the Business Finland financial support!
